Quality of life in adults with dysferlinopathy: international clinical outcome study of dysferlinopathy

被引：0

作者：

Hilsden, H. ^{[1
,2
]}

James, M. ^{[1
,2
]}

Dressman, H. Gordish ^{[3
,4
]}

Day, J. ^{[5
]}

Mendell, J. ^{[6
]}

Torron, R. Fernandez ^{[7
]}

Harms, M. ^{[8
]}

Pestronk, A. ^{[9
]}

Vissing, J. ^{[10
]}

Desai, U. ^{[11
]}

Yoshimura, M. ^{[12
]}

Shin, J. ^{[13
]}

Mozaffar, T. ^{[14
]}

Stojkovic, T. ^{[15
]}

Pegoraro, E. ^{[16
]}

Raivas, J. Bevilacqu ^{[17
]}

Olive, M. ^{[18
]}

Paradas, C. ^{[19
]}

Straub, V. ^{[1
,2
]}

Mayhew, A. ^{[1
,2
]}

机构：

[1] Newcastle Univ, Translat & Clin Res Inst, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England

[2] Newcastle Hosp NHS Fdn Trust, Newcastle, NSW, Australia

[3] Childrens Nat Hlth Syst, Div Biostats Study Methodol, Ctr Translat Sci, Washington, DC USA

[4] George Washington Univ, Paediat Epidemiol & Biostat, Washington, DC USA

[5] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA

[6] Nationwide Ch Hosp, Columbus, OH USA

[7] Donostia Univ Hosp, Biodonostia Hlth Res Inst, Neurol Serv, Neuromuscular Area, Donostia San Sebastian, Spain

[8] Columbia Univ, Dept Neurol, Irving Med Ctr, New York, NY USA

[9] Washington Univ, Dept Neurol, Sch Med, St Louis, MO USA

[10] Univ Copenhagen, Dept Neurol, Rigshosp, Copenhagen Neuromusc Ctr, Copenhagen, Denmark

[11] Atrium Hlth, Carolinas MDA Care Ctr, Charlotte, NC USA

[12] NCNP, Dept Neurol, Nat Ctr Hosp, Tokyo, Japan

[13] Pusan Natl Univ, Lab Mol Neurol, Yangsan Hosp, Yangsan, South Korea

[14] Univ Calif Irvine, Dept Neurol, MDA ALS & Neuromusc Ctr, Orange, CA USA

[15] Grp Hosp Pitie Salpetriere, Inst Myol, Paris, France

[16] Univ Padua, Dept Neurosci, Padua, Italy

[17] Clin Davila, Dept Neurol & Neurocirugia Clin, Santiago, Chile

[18] Hosp Santa Creu & Sant Pau, Dept Neurol, Neuromusc Disord Unit, Barcelona, Spain

[19] Hosp Univ Virgen del Rocio, Dept Neurol, Neuromuscular Unit, Inst Biomed Sevilla, Seville, Spain

来源：

NEUROMUSCULAR DISORDERS | 2023年 / 33卷

关键词：

D O I：

10.1016/j.nmd.2023.07.191

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P281

引用

页码：S113 / S113

页数：1

共 50 条

[21] Clinical outcome study of dysferlinopathy: Performance of upper limb entry item to predict forced vital capacity in dysferlinopathy (LGMDR2)
James, M.
Dressman, H. Gordish
Hilsden, H.
Rufibach, L.
Human, A.
Duong, T.
Maron, E.
DeWolf, B.
Rose, K.
Siener, C.
Thiele, S.
Sanchez-Aguilera Praxedes, N.
Canal, A.
Holsten, S.
Sakamoto, C.
Pedrosa-Hernandez, I.
Bello, L.
Alfano, L.
Lowes, L. Pax
Straub, V.
Mayhew, A.
NEUROMUSCULAR DISORDERS, 2022, 32 : S114 - S114
[22] Clinical outcome study for dysferlinopathy: Sensitivity of outcome measures over one-year
Moore, U.
James, M.
Mayhew, A.
Jacobs, M.
Feng, J.
Harris, E.
Fernandez-Torron, R.
Bettinson, K.
Hilsden, H.
Rufibach, L.
Cnaan, A.
Straub, V.
Bushby, K.
NEUROMUSCULAR DISORDERS, 2017, 27 : S8 - S8
[23] Clinical outcome study for dysferlinopathy: One-year follow-up
Paradas, C.
Moore, U.
James, M.
Mayhew, A.
Azzabou, N.
Torron, R. Fernandez
Reyngoudt, H.
Smith, F.
Harris, E.
Bettinson, K.
Hilsden, H.
Jacobs, M.
Feng, J.
Cnaan, A.
Rufibach, L.
Eagle, M.
Blamire, A.
Carlier, P.
Bushby, K.
NEUROMUSCULAR DISORDERS, 2016, 26 : S92 - S93
[24] Quality of life in dysferlinopathy can be good despite poor function
Moore, U.
James, M.
Spuler, S.
Day, J.
Jones, K.
Bharucha-Goebel, D.
Salort-Campana, E.
Pestronk, A.
Walter, M.
Paradas, C.
Stojkovic, T.
Yoshimura, M. Mori
Bravver, E.
Pegoraro, E.
Mendell, J.
Bushby, K.
Straub, V.
Mayhew, A.
NEUROMUSCULAR DISORDERS, 2021, 31 : S104 - S104
[25] CLINICAL OUTCOME STUDY FOR DYSFERLINOPATHY: THREE YEARS OF NATURAL HISTORY DATA FOR CLINICAL TRIAL READINESS
James, M. K.
Mayhew, A. G.
Jacobs, M.
Eagle, M.
Maron, E.
Gee, R.
Harman, M.
Duong, T.
Vandervelde, B.
Siener, C.
Thiele, S.
Mendez, B.
Canal, A.
Sakamoto, C.
Holsten, S.
Pedrosa Belmonte, I.
Semplicini, C.
Alfano, L.
Lowes, L.
Straub, V.
MUSCLE & NERVE, 2018, 58 : S3 - S3
[26] Dysferlinopathy: Clinical aspects in India
Hattori, Hidenori
Suzuki, Norihiro
NEUROLOGY INDIA, 2008, 56 (03) : 386 - 387
[27] The clinical outcome study for dysferlinopathy: quantitative MRI and physiotherapy outcomes to capture disease progression
James, M.
Smith, F.
Reyngoudt, H.
Wilson, I.
Mayhew, A.
Fernandez-Torron, R.
Araujo, E.
Stojkovic, T.
Blamire, A.
Carlier, P.
Straub, V.
NEUROMUSCULAR DISORDERS, 2019, 29 : S103 - S103
[28] Clinical outcome study for dysferlinopathy: three years of natural history data for clinical trial readiness
James, M.
Mayhew, A.
Lofra, R. Muni
Jacobs, M.
Canal, A.
Duong, T.
Gee, R.
Harman, M.
Holsten, S.
Lowes, L.
Maron, E.
Mendez, B.
Pedrosa Belmonte, I.
Sakamoto, C.
Semplicini, C.
Siener, C.
Thiele, S.
Vandervelde, B.
Bushby, K.
Straub, V.
NEUROMUSCULAR DISORDERS, 2018, 28 : S33 - S34
[29] Dysferlinopathy in Egypt: Clinical and pathological characteristics
Fahmy, N.
Abd-elhady, A.
El-Naser, A. Abd
Ashour, S.
Nonaka, I.
Etribi, A.
NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 584 - 585
[30] Dysferlinopathy in Iran: Clinical and genetic report
Fatehi, Farzad
Nafissi, Shahriar
Urtizberea, J. Andoni
Blanck-Labelle, Veronique
Levy, Nicolas
Krahn, Martin
Dbouk, Mohamad Baker
Attarian, Shahram
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 359 (1-2) : 256 - 259

← 1 2 3 4 5 →